BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14555276)

  • 1. Hyaluronic acid reverses the abnormal synthetic activity of human osteoarthritic subchondral bone osteoblasts.
    Lajeunesse D; Delalandre A; Martel-Pelletier J; Pelletier JP
    Bone; 2003 Oct; 33(4):703-10. PubMed ID: 14555276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
    Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
    Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients.
    Massicotte F; Lajeunesse D; Benderdour M; Pelletier JP; Hilal G; Duval N; Martel-Pelletier J
    Osteoarthritis Cartilage; 2002 Jun; 10(6):491-500. PubMed ID: 12056853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
    Hilal G; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
    Arthritis Rheum; 1999 Oct; 42(10):2112-22. PubMed ID: 10524682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts.
    Hilal G; Massicotte F; Martel-Pelletier J; Fernandes JC; Pelletier JP; Lajeunesse D
    J Bone Miner Res; 2001 Apr; 16(4):713-21. PubMed ID: 11315999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts.
    Massicotte F; Fernandes JC; Martel-Pelletier J; Pelletier JP; Lajeunesse D
    Bone; 2006 Mar; 38(3):333-41. PubMed ID: 16257278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
    Pelletier JP; Lajeunesse D; Reboul P; Mineau F; Fernandes JC; Sabouret P; Martel-Pelletier J
    J Rheumatol; 2001 Apr; 28(4):814-24. PubMed ID: 11327257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis.
    Lajeunesse D; Martel-Pelletier J; Fernandes JC; Laufer S; Pelletier JP
    Ann Rheum Dis; 2004 Jan; 63(1):78-83. PubMed ID: 14672896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic positive effect of formononetin on metabolic activity of human normal and osteoarthritic subchondral osteoblasts.
    Huh JE; Seo DM; Baek YH; Choi DY; Park DS; Lee JD
    Int Immunopharmacol; 2010 Apr; 10(4):500-7. PubMed ID: 20138155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the role of leukotriene B()4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition.
    Paredes Y; Massicotte F; Pelletier JP; Martel-Pelletier J; Laufer S; Lajeunesse D
    Arthritis Rheum; 2002 Jul; 46(7):1804-12. PubMed ID: 12124864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts.
    Massicotte F; Aubry I; Martel-Pelletier J; Pelletier JP; Fernandes J; Lajeunesse D
    Arthritis Res Ther; 2006; 8(6):R177. PubMed ID: 17129375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of resveratrol on phenotypic features and activity of osteoarthritic osteoblasts.
    Abed É; Delalandre A; Lajeunesse D
    Arthritis Res Ther; 2017 Jun; 19(1):151. PubMed ID: 28666466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Lu KH
    J Orthop Res; 2008 Apr; 26(4):475-84. PubMed ID: 17975844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression.
    Mutabaruka MS; Aoulad Aissa M; Delalandre A; Lavigne M; Lajeunesse D
    Arthritis Res Ther; 2010; 12(1):R20. PubMed ID: 20141628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-articular injection of hyaluronan restores the aberrant expression of matrix metalloproteinase-13 in osteoarthritic subchondral bone.
    Hiraoka N; Takahashi KA; Arai Y; Sakao K; Mazda O; Kishida T; Honjo K; Tanaka S; Kubo T
    J Orthop Res; 2011 Mar; 29(3):354-60. PubMed ID: 20886647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca2+ pathways in human osteoarthritis osteoblasts.
    Martineau X; Abed É; Martel-Pelletier J; Pelletier JP; Lajeunesse D
    PLoS One; 2017; 12(8):e0180711. PubMed ID: 28777797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activity of osteoblasts retrieved from osteoarthritic patients after stimulation with mediators involved in periprosthetic loosening.
    Lavigne P; Shi Q; Lajeunesse D; Dehnade F; Fernandes JC
    Bone; 2004 Mar; 34(3):478-86. PubMed ID: 15003795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
    Pelletier JP; Lajeunesse D; Jovanovic DV; Lascau-Coman V; Jolicoeur FC; Hilal G; Fernandes JC; Martel-Pelletier J
    J Rheumatol; 2000 Dec; 27(12):2893-902. PubMed ID: 11128682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
    Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
    J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.